# Henry W. Long

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/henry-w-long/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,942 |
| Field | Epigenetics and DNA Methylation |
| h-index | 57 |
| i10-index | 112 |
| Last Known Institution | Dana-Farber Cancer Institute |
| OpenAlex ID | https://openalex.org/A5066070097 |
| ORCID iD | 0000-0001-6849-6629 |
| Works | 650 |

## Researcher papers

- [<i>Rb1</i> and <i>Trp53</i> cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance](https://scholariq.org/papers/i-rb1-i-and-i-trp53-i-cooperate-to-suppress-prostate-cancer-lineage-plasticity/)
- [A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing](https://scholariq.org/papers/a-major-chromatin-regulator-determines-resistance-of-tumor-cells-to-t-cell/)
- [Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer](https://scholariq.org/papers/response-and-resistance-to-bet-bromodomain-inhibitors-in-triple-negative-breast/)
- [The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis](https://scholariq.org/papers/the-androgen-receptor-cistrome-is-extensively-reprogrammed-in-human-prostate/)
- [Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway](https://scholariq.org/papers/treatment-induced-tumor-dormancy-through-yap-mediated-transcriptional/)
- [HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia](https://scholariq.org/papers/hif1a-employs-cdk8-mediator-to-stimulate-rnapii-elongation-in-response-to/)
- [A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer](https://scholariq.org/papers/a-somatically-acquired-enhancer-of-the-androgen-receptor-is-a-noncoding-driver/)
- [The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice](https://scholariq.org/papers/the-public-repository-of-xenografts-enables-discovery-and-randomized-phase-ii/)
- [Prostate cancer reactivates developmental epigenomic programs during metastatic progression](https://scholariq.org/papers/prostate-cancer-reactivates-developmental-epigenomic-programs-during-metastatic/)
- [Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade](https://scholariq.org/papers/therapeutically-increasing-mhc-i-expression-potentiates-immune-checkpoint/)
- [Detecting Small Cell Transformation in Patients with Advanced <i>EGFR</i> Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling](https://scholariq.org/papers/detecting-small-cell-transformation-in-patients-with-advanced-i-egfr-i-mutant/)

## Researcher topics

- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Researcher university

- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.